この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2025/3/251 分で読めます
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
ローカル自動翻訳 · 情報源の原言語
概要
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →